293 related articles for article (PubMed ID: 32915499)
1. Pan-cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potential.
Li H; Liu J; Shen S; Dai D; Cheng S; Dong X; Sun L; Guo X
J Cell Mol Med; 2020 Oct; 24(19):11111-11119. PubMed ID: 32915499
[TBL] [Abstract][Full Text] [Related]
2. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
3. Identification of HnRNP Family as Prognostic Biomarkers in Five Major Types of Gastrointestinal Cancer.
Chen X; Gong R; Wang J; Ma B; Lei K; Ren H; Wang J; Zhao C; Wang L; Yu Q
Curr Gene Ther; 2022; 22(5):449-461. PubMed ID: 35794744
[TBL] [Abstract][Full Text] [Related]
4. Identification of Upregulated HNRNPs Associated with Poor Prognosis in Pancreatic Cancer.
Qiao L; Xie N; Bai Y; Li Y; Shi Y; Wang J; Liu N
Biomed Res Int; 2019; 2019():5134050. PubMed ID: 31355266
[TBL] [Abstract][Full Text] [Related]
5. Rare deleterious mutations of HNRNP genes result in shared neurodevelopmental disorders.
Gillentine MA; Wang T; Hoekzema K; Rosenfeld J; Liu P; Guo H; Kim CN; De Vries BBA; Vissers LELM; Nordenskjold M; Kvarnung M; Lindstrand A; Nordgren A; Gecz J; Iascone M; Cereda A; Scatigno A; Maitz S; Zanni G; Bertini E; Zweier C; Schuhmann S; Wiesener A; Pepper M; Panjwani H; Torti E; Abid F; Anselm I; Srivastava S; Atwal P; Bacino CA; Bhat G; Cobian K; Bird LM; Friedman J; Wright MS; Callewaert B; Petit F; Mathieu S; Afenjar A; Christensen CK; White KM; Elpeleg O; Berger I; Espineli EJ; Fagerberg C; Brasch-Andersen C; Hansen LK; Feyma T; Hughes S; Thiffault I; Sullivan B; Yan S; Keller K; Keren B; Mignot C; Kooy F; Meuwissen M; Basinger A; Kukolich M; Philips M; Ortega L; Drummond-Borg M; Lauridsen M; Sorensen K; Lehman A; ; Lopez-Rangel E; Levy P; Lessel D; Lotze T; Madan-Khetarpal S; Sebastian J; Vento J; Vats D; Benman LM; Mckee S; Mirzaa GM; Muss C; Pappas J; Peeters H; Romano C; Elia M; Galesi O; Simon MEH; van Gassen KLI; Simpson K; Stratton R; Syed S; Thevenon J; Palafoll IV; Vitobello A; Bournez M; Faivre L; Xia K; ; Earl RK; Nowakowski T; Bernier RA; Eichler EE
Genome Med; 2021 Apr; 13(1):63. PubMed ID: 33874999
[TBL] [Abstract][Full Text] [Related]
6. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
7. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.
Wang N; Zhu L; Wang L; Shen Z; Huang X
Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
[TBL] [Abstract][Full Text] [Related]
8. The hnRNP family: insights into their role in health and disease.
Geuens T; Bouhy D; Timmerman V
Hum Genet; 2016 Aug; 135(8):851-67. PubMed ID: 27215579
[TBL] [Abstract][Full Text] [Related]
9. Identifies microtubule-binding protein
Wang W; Zhang J; Wang Y; Xu Y; Zhang S
Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625
[TBL] [Abstract][Full Text] [Related]
10. Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma.
Zhou J; Guo Y; Huo Z; Xing Y; Fang J; Ma G; Han Q; Wang M; Xu Q
Aging (Albany NY); 2021 Jan; 13(3):4503-4521. PubMed ID: 33495416
[TBL] [Abstract][Full Text] [Related]
11. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs).
Motta-Mena LB; Smith SA; Mallory MJ; Jackson J; Wang J; Lynch KW
J Biol Chem; 2011 Jun; 286(22):20043-53. PubMed ID: 21507955
[TBL] [Abstract][Full Text] [Related]
12. Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA.
Ye B; Shi J; Kang H; Oyebamiji O; Hill D; Yu H; Ness S; Ye F; Ping J; He J; Edwards J; Zhao YY; Guo Y
RNA Biol; 2020 Nov; 17(11):1666-1673. PubMed ID: 31607216
[TBL] [Abstract][Full Text] [Related]
13. Research Progress on the Structural and Functional Roles of hnRNPs in Muscle Development.
Li Z; Wei H; Hu D; Li X; Guo Y; Ding X; Guo H; Zhang L
Biomolecules; 2023 Sep; 13(10):. PubMed ID: 37892116
[TBL] [Abstract][Full Text] [Related]
14. Pan-cancer analysis of the oncogenic role of HNRNPR in human tumors.
Yang Y; Sun JD; Xiang ZL
Cell Biol Int; 2023 Aug; 47(8):1406-1426. PubMed ID: 37077028
[TBL] [Abstract][Full Text] [Related]
15. Auto- and cross-regulation of the hnRNPs D and DL.
Kemmerer K; Fischer S; Weigand JE
RNA; 2018 Mar; 24(3):324-331. PubMed ID: 29263134
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint.
Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ
Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930
[TBL] [Abstract][Full Text] [Related]
17. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis.
Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K
Front Immunol; 2022; 13():903461. PubMed ID: 35663977
[TBL] [Abstract][Full Text] [Related]
18. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing.
Ji Y; Tulin AV
Nucleic Acids Res; 2009 Jun; 37(11):3501-13. PubMed ID: 19346337
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm.
Kim JH; Hahm B; Kim YK; Choi M; Jang SK
J Mol Biol; 2000 May; 298(3):395-405. PubMed ID: 10772858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
